Test Directory
| Test Code | |||||
| COCAB | |||||
| Test Name | |||||
| Coccidioides Antibodies, IgM and IgG by ELISA | |||||
| CPT Codes | |||||
| 86635 X 2 | |||||
| Included Tests | |||||
|
|||||
| Expected Turnaround Time | |||||
| 1 - 2 day | |||||
| Clinical Utility | |||||
|
Qualitative detection of antibodies against the fungus Coccidioides to aid in the diagnosis of Coccidioidomycosis (Valley Fever). Specimens positive for Coccidioides antibody by EIA should be confirmed by additional testing (complement fixation and immunodiffusion). Coccidioides live in the dust and soil in some areas of the southwestern United States, Mexico, and South America. In the U.S., Coccidioides live in Arizona, California, Nevada, New Mexico, Texas, and Utah. Many people who are exposed to Coccidioides never develop symptoms. In symptomatic individuals (Valley Fever), symptoms may appear between 1 to 3 weeks after they breathe in fungal spores and usually last for a few weeks to months. Approximately 5% to 10% of people who get Valley Fever will develop serious or long-term problems of the lungs. In approximately 1% of people the infection spreads from the lungs to other parts of the body, such as the central nervous system, skin, or bones and joints. The IgM antibody response (early infection) is measured against the tube precipitin (TP) antigen, and IgG antibody response (late infection) is measured against complement fixation (CF) antigen. |
|||||
| Specimen and Container Info | |||||
|
Specimen Type: Serum
Collection Container: Gold Top, Serum Separator Alternate Collection Container: Red Top, Plain Desired Specimen Volume: 1 mL |
|||||
| Collection Instructions | |||||
|
|||||
| Processing and Submission Instructions | |||||
|
|||||
| Transport Instructions | |||||
|
Transport to the laboratory refrigerated. |
|||||
| Stability Requirements | |||||
|
|||||
| Methodology | |||||
| EIA/ELISA | |||||
| Reference Intervals | |||||
|
See patient report. |
|||||
| Limitations | |||||
|
Specimens positive for Coccidioides antibody by EIA should be confirmed by additional testing (complement fixation and immunodiffusion). A negative result with both IgM and IgG does not preclude diagnosis of coccidioidomycosis. False-positive due to cross-reactivity has been observed in individuals with other fungal diseases. Diagnosis of coccidioidomycosis should be based on laboratory and clinical findings. |
|||||
| Alternate Names | |||||
|
|||||
| Reference Lab | |||||
| Labcorp Of America Holdings | |||||
| Testing Schedule | |||||
| Monday-Friday | |||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.